Douglass Winthrop Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$485K Buy
1,817
+44
+2% +$11.9K 0.01% 210
2025
Q4
$445K Buy
1,773
+356
+25% +$94.5K 0.01% 225
2025
Q3
$407K Sell
1,417
-273
-16% -$73.1K 0.01% 226
2025
Q2
$444K Sell
1,690
-150
-8% -$36.5K 0.01% 195
2025
Q1
$428K Buy
1,840
+25
+1% +$6.07K 0.01% 204
2024
Q4
$416K Buy
1,815
+25
+1% +$5.74K 0.01% 219
2024
Q3
$400K Sell
1,790
-25
-1% -$5.5K 0.01% 218
2024
Q2
$369K Buy
1,815
+25
+1% +$5.08K 0.01% 218
2024
Q1
$391K Sell
1,790
-225
-11% -$49.6K 0.01% 209
2023
Q4
$458K Sell
2,015
-225
-10% -$47.3K 0.01% 183
2023
Q3
$450K Sell
2,240
-1,246
-36% -$263K 0.01% 171
2023
Q2
$723K Sell
3,486
-233
-6% -$45.2K 0.02% 141
2023
Q1
$733K Buy
3,719
+122
+3% +$25.1K 0.02% 138
2022
Q4
$728K Hold
3,597
0.02% 139
2022
Q3
$633K Sell
3,597
-29
-0.8% -$5.94K 0.02% 140
2022
Q2
$730K Hold
3,626
0.02% 139
2022
Q1
$821K Sell
3,626
-29
-0.8% -$6.82K 0.02% 144
2021
Q4
$987K Sell
3,655
-233
-6% -$57.7K 0.02% 134
2021
Q3
$940K Hold
3,888
0.02% 139
2021
Q2
$921K Buy
3,888
+233
+6% +$53.1K 0.02% 146
2021
Q1
$801K Hold
3,655
0.02% 154
2020
Q4
$639K Sell
3,655
-7
-0.2% -$1.21K 0.02% 164
2020
Q3
$592K Buy
3,662
+1,520
+71% +$241K 0.02% 158
2020
Q2
$306K Buy
+2,142
New +$296K 0.01% 211
2019
Q3
Sell
-1,705
Closed -$253K 262
2019
Q2
$253K Hold
1,705
0.01% 234
2019
Q1
$224K Sell
1,705
-3,632
-68% -$447K 0.01% 225
2018
Q4
$579K Hold
5,337
0.03% 150
2018
Q3
$796K Sell
5,337
-3,492
-40% -$531K 0.04% 132
2018
Q2
$1.36M Buy
8,829
+3,492
+65% +$527K 0.06% 127
2018
Q1
$742K Buy
5,337
+1,135
+27% +$167K 0.04% 165
2017
Q4
$576K Hold
4,202
0.03% 160
2017
Q3
$545K Buy
4,202
+495
+13% +$66K 0.03% 163
2017
Q2
$491K Hold
3,707
0.03% 165
2017
Q1
$457K Hold
3,707
0.03% 170
2016
Q4
$409K Hold
3,707
0.03% 171
2016
Q3
$438K Buy
3,707
+75
+2% +$8.84K 0.03% 166
2016
Q2
$406K Hold
3,632
0.03% 169
2016
Q1
$365K Hold
3,632
0.03% 172
2015
Q4
$386K Buy
3,632
+722
+25% +$74.5K 0.03% 176
2015
Q3
$271K Hold
2,910
0.02% 202
2015
Q2
$315K Hold
2,910
0.02% 198
2015
Q1
$315K Sell
2,910
-29
-1% -$2.98K 0.02% 198
2014
Q4
$272K Sell
2,939
-227
-7% -$20.1K 0.02% 179
2014
Q3
$277K Sell
3,166
-183,464
-98% -$16.6M 0.03% 172
2014
Q2
$16.4M Buy
186,630
+826
+0.4% +$71.5K 1.51% 28
2014
Q1
$15.7M Buy
185,804
+12,967
+8% +$1.03M 1.55% 27
2013
Q4
$13.6M Buy
172,837
+7,584
+5% +$647K 1.41% 29
2013
Q3
$14.1M Buy
165,253
+4,656
+3% +$392K 1.63% 26
2013
Q2
$13.8M Buy
+160,597
New +$13.3M 1.67% 24

Other funds holding LH

Douglass Winthrop Advisors's LH Position: Q1 2026 in Review

Douglass Winthrop Advisors increased its Labcorp (LH) stake by 2.5% in Q1 2026, buying an estimated $11.9K and bringing the position to 1,817 shares worth $485K. The position accounts for 0.01% of the portfolio, ranked #210.

Douglass Winthrop Advisors first reported a position in LH in Q2 2013 and has held it in 49 quarters since. The position peaked at $16.4M in Q2 2014. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Douglass Winthrop Advisors held 1,817 shares of Labcorp worth $485K as of Q1 2026.
  • Douglass Winthrop Advisors bought 44 Labcorp shares in Q1 2026, an estimated $11.9K.
  • Labcorp made up 0.01% of Douglass Winthrop Advisors's portfolio in Q1 2026, its #210 holding.
  • Douglass Winthrop Advisors first reported a position in Labcorp in Q2 2013 and has held it in 49 quarters since.
  • Douglass Winthrop Advisors's Labcorp position peaked at $16.4M in Q2 2014.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Douglass Winthrop Advisors's 13F filing for Q1 2026, filed 14 May 2026.